Range Low Price High Price Comment
30 days $36.77 $55.69 Wednesday, 1st May 2024 BHVN stock ended at $40.18. This is 3.56% more than the trading day before Tuesday, 30th Apr 2024. During the day the stock fluctuated 8.34% from a day low at $38.43 to a day high of $41.64.
90 days $36.77 $62.21
52 weeks $13.03 $62.21

Historical Biohaven Pharmaceutical Holding Company Ltd prices

Date Open High Low Close Volume
Feb 20, 2024 $48.92 $50.68 $46.98 $47.24 942 867
Feb 16, 2024 $48.86 $50.22 $48.44 $49.50 658 457
Feb 15, 2024 $47.57 $49.25 $47.57 $49.11 605 774
Feb 14, 2024 $48.00 $48.92 $45.70 $47.12 562 564
Feb 13, 2024 $46.90 $48.26 $46.05 $46.95 992 901
Feb 12, 2024 $49.28 $50.23 $47.97 $48.71 486 340
Feb 09, 2024 $47.12 $48.93 $47.12 $48.55 495 510
Feb 08, 2024 $47.26 $48.20 $46.18 $46.92 472 323
Feb 07, 2024 $47.27 $48.19 $46.93 $47.26 397 021
Feb 06, 2024 $47.77 $48.58 $46.57 $47.21 699 698
Feb 05, 2024 $44.79 $47.50 $44.26 $47.16 936 326
Feb 02, 2024 $44.06 $45.06 $43.05 $44.79 542 538
Feb 01, 2024 $44.92 $45.74 $43.94 $45.00 559 819
Jan 31, 2024 $43.89 $46.37 $43.89 $44.48 761 487
Jan 30, 2024 $45.25 $45.90 $43.65 $43.81 950 117
Jan 29, 2024 $45.50 $46.61 $44.90 $45.67 757 477
Jan 26, 2024 $45.10 $45.45 $44.19 $44.89 500 997
Jan 25, 2024 $46.09 $47.27 $44.90 $44.97 738 678
Jan 24, 2024 $49.10 $49.58 $45.33 $45.60 573 325
Jan 23, 2024 $49.03 $49.65 $46.88 $48.31 1 175 648
Jan 22, 2024 $44.91 $48.70 $44.82 $48.45 1 333 056
Jan 19, 2024 $42.80 $44.35 $42.02 $44.35 924 382
Jan 18, 2024 $43.80 $44.15 $42.20 $42.71 900 041
Jan 17, 2024 $44.08 $44.18 $42.80 $43.49 1 208 675
Jan 16, 2024 $44.50 $45.59 $43.54 $44.60 706 169
Click to get the best stock tips daily for free!

About Biohaven Pharmaceutical Holding Company Ltd

Biohaven Pharmaceutical Holding Company Ltd Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavegepant that is in phase III clinical trials for acute and preventive treatment of migraine, as well as re... BHVN Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT